ArticleHospital pediatrics2024
Performance of AAP CPG for Ineligible Well-Appearing Febrile Infants Aged 8-60 Days.
Article in Hospital pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesThe AAP's Clinical Practice Guidelines (CPG) for febrile infants provides recommendations in evaluating well-appearing febrile infants aged 8-60 days at risk for invasive bacterial infections (IBIs; ie, bacteremia and bacterial meningitis). However, guidance remains limited for the infants excluded from (ie, ineligible for) the CPG. The objectives are to estimate the proportion of well-appearing CPG-ineligible febrile infants and to examine CPG performance in detecting IBIs for CPG-ineligible febrile infants.
methodsWe performed a secondary analysis of single-site data collected for a prior study from 2011 to 2018. Infants were included if they were 8-60 days and well-appearing. We stratified IBI risk using age and CPG inflammatory marker thresholds for temperature, absolute neutrophil count, and C-reactive protein. We conducted analyses on CPG-ineligible infants and CPG-eligible infants. We estimated the areas under the receiver operating characteristics curve, sensitivity, and specificity of both approaches in detecting IBIs.
resultsOf 648 infants, 22% did not meet CPG eligibility. Sensitivities for both analyses were 100% with specificities for CPG-ineligible and eligible of 38.1% (95% CI, 30-47) and 38.2% (95% CI, 33.9-42.6), respectively.
conclusionsStrict adherence to the CPG may result in a substantial proportion of ineligible infants. Findings suggest that CPG-based approaches can maintain high sensitivities for all febrile infants, including CPG-ineligible infants. Future studies should examine the contribution of specific conditions (eg, preterm birth) to IBI risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.